A rare and aggressive form of liver cancer has long resisted immunotherapy, a treatment that helps the body's own immune…
Chronic kidney disease (CKD) affects hundreds of millions of people worldwide and is one of the leading causes of kidney…
Researchers led by metabolism expert Prof Timo D. Müller at Helmholtz Munich have developed a new strategy to treat obesity…
Medications used to treat type 2 diabetes and obesity, including well-known brands like Ozempic and Wegovy, may offer unexpected mental…
GLP-1 medications, such as semaglutide (Ozempic, Wegovy, and Rybelsus), commonly prescribed for diabetes and obesity may also be linked to…
Lecanemab, marketed as Leqembi, is a monoclonal antibody treatment for Alzheimer's disease that targets and removes harmful amyloid plaques while…
Researchers at the University of Cambridge have created a new technique that uses light instead of toxic chemicals to change…
Researchers have uncovered a promising new treatment target for a severe autoimmune brain disorder. The finding could help drive the…
A research team led by scientists from several Japanese institutions has identified a compound called Mic-628 that directly influences the…
Three newly identified compounds were found to strongly inhibit α-glucosidase, an enzyme that plays a central role in breaking down…